Brian Oneill
Family Medicine · Belleville, ILNPI 1669466066
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,193 and has fallen 97.6% since, to $29 in 2024.
Across 216 payments — averaging $12.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$457
- AstraZeneca$448
- Johnson & Johnson$234
- Lilly USA, LLC$230
- Teva Pharmaceuticals USA, Inc.$170
- Amarin Pharma, Inc.$154
- plus $905 from 26 others
What the payments were for
- Food & beverage$2,590100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 48 | $457 |
| AstraZeneca | 33 | $448 |
| Johnson & Johnson | 15 | $234 |
| Lilly USA, LLC | 23 | $230 |
| Teva Pharmaceuticals USA, Inc. | 21 | $170 |
| Amarin Pharma, Inc. | 10 | $154 |
| Sanofi-aventis U.S. LLC | 8 | $113 |
| Amgen | 5 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $73 |
| Pfizer | 5 | $69 |
| Dexcom, Inc. | 4 | $61 |
| AbbVie | 4 | $52 |
| Eisai Inc. | 3 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| Biohaven Pharmaceuticals, Inc. | 3 | $43 |
| Astellas Pharma US Inc | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Novartis | 2 | $27 |
| Daiichi Sankyo Inc. | 2 | $27 |
| Mannkind Corporation | 2 | $27 |
| Boehringer Ingelheim | 2 | $24 |
| Zyla Life Sciences, Inc. | 2 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Optinose US, Inc. | 1 | $16 |
| Abbott | 1 | $15 |
| Shire North American Group Inc | 1 | $15 |
| GSK | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
| IBSA Pharma Inc. | 1 | $12 |
| Nestle Healthcare Nutrition Inc. | 1 | $11 |
How this compares
$2,598 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Belleville
- David RawdonBelleville$20K
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.